Outlook Therapeutics, Inc. (OTLK)

Outlook Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Year Ending	Current	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019
Market Capitalization	186	58	276	380	92	42
Market Cap Growth	-44.46%	-79.15%	-27.49%	315.51%	117.68%	-40.54%
Enterprise Value	184	70	269	378	80	45
PE Ratio	-	-0.97	-4.18	-7.16	-1.87	-1.17
PS Ratio	-	-	-	-	-	5.16
PB Ratio	-1.16	-3.98	31.58	82.58	32.40	-2.61
P/FCF Ratio	-2.67	-1.34	-4.87	-7.01	-2.88	-1.29
P/OCF Ratio	-2.67	-1.34	-4.87	-7.01	-2.88	-1.30
EV/Sales Ratio	-	-	-	-	-	5.57
EV/EBITDA Ratio	-0.97	-1.21	-4.19	-7.27	-2.22	-1.46
EV/EBIT Ratio	-0.97	-1.21	-4.17	-7.24	-2.18	-1.32
EV/FCF Ratio	-2.62	-1.62	-4.75	-6.97	-2.52	-1.39
Debt / Equity Ratio	-0.33	-2.46	1.25	2.58	0.43	-0.70
Debt / EBITDA Ratio	-0.29	-0.62	-0.17	-0.23	-0.03	-0.36
Debt / FCF Ratio	-0.77	-0.83	-0.19	-0.22	-0.04	-0.35
Quick Ratio	0.87	0.50	0.88	2.14	0.79	0.40
Current Ratio	1.07	0.66	1.40	3.19	1.13	0.67
Asset Turnover	0	0	0	0	0	0.38
Interest Coverage	-71.52	-36.81	-43.40	-55.79	-20.93	-9.94
Return on Equity (ROE)	356.60%	-3741.50%	-232.60%	-772.40%	519.00%	186.90%
Return on Assets (ROA)	-404.20%	-122.00%	-123.80%	-187.70%	-265.70%	-167.20%
Return on Capital (ROIC)	66.89%	-251.58%	-320.24%	-313.31%	-911.78%	756.89%
Earnings Yield	-85.41%	-102.55%	-23.94%	-13.97%	-53.37%	-85.67%
FCF Yield	-31.27%	-74.72%	-20.54%	-14.26%	-34.72%	-77.80%
Buyback Yield / Dilution	-11.20%	-17.96%	-38.91%	-110.43%	-298.84%	-268.84%
Total Shareholder Return	-11.20%	-17.96%	-38.91%	-110.43%	-298.84%	-268.84%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).